Affiliation:
1. St John’s Institute of Dermatology, King’s College London, London SE1 9RT, UK
Abstract
Genodermatoses encompass a wide range of inherited skin diseases, many of which are monogenic. Genodermatoses range in severity and result in early-onset cancers or life-threatening damage to the skin, and there are few curative options. As such, there is a clinical need for single-intervention treatments with curative potential. Here, we discuss the nascent field of gene editing for the treatment of genodermatoses, exploring CRISPR–Cas9 and homology-directed repair, base editing, and prime editing tools for correcting pathogenic mutations. We specifically focus on the optimisation of editing efficiency, the minimisation off-targets edits, and the tools for delivery for potential future therapies. Honing each of these factors is essential for translating gene editing therapies into the clinical setting. Therefore, the aim of this review article is to raise important considerations for investigators aiming to develop gene editing approaches for genodermatoses.
Funder
Wellcome Trust
CureEB Charity
EB Medical Research Foundation
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference157 articles.
1. Gene Therapy for Epidermolysis Bullosa: Sticky Business;Mol. Ther. J. Am. Soc. Gene Ther.,2016
2. Treatment of Rare Keratinization Disorders: What’s New?;Vahlquist;Expert Rev. Dermatol.,2011
3. TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery;Nemudryi;Acta Nat.,2014
4. Dupuy, A., Valton, J., Leduc, S., Armier, J., Galetto, R., Gouble, A., Lebuhotel, C., Stary, A., Pâques, F., and Duchateau, P. (2013). Targeted Gene Therapy of Xeroderma Pigmentosum Cells Using Meganuclease and TALENTM. PLoS ONE, 8.
5. TALEN-Based Gene Correction for Epidermolysis Bullosa;Osborn;Mol. Ther.,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献